Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22. Okt. 2024–24. Okt. 2024 Malham Saudi-Arabien
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22. Okt. 2024–24. Okt. 2024 Malham Saudi-Arabien
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22. Okt. 2024–24. Okt. 2024 Malham Saudi-Arabien
News 24. Jan. 2024 Odne secures fifth investment from the Dental Innovation Alliance The North American venture capital firm Dental Innovation Alliance has made a fifth investment in Odne. This will support the market launch of an...
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22. Okt. 2024–24. Okt. 2024 Malham Saudi-Arabien
News 27. Okt. 2023 Roche uses artificial intelligence for cancer diagnosis Roche is teaming up with Ibex Medical Analytics and Amazon Web Services in the field of artificial intelligence (AI). The goal is to help patholo...
News 21. Nov. 2023 CRISPR Therapeutics and Vertex awarded historic authorization The two partners CRISPR Therapeutics and Vertex have secured the world’s first approval for a genome editing therapy based on what are known as g...
News 18. Okt. 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
Aktuell 21. Nov. 2023 CRISPR Therapeutics und Vertex erhalten historische Zulassung Die Partner CRISPR Therapeutics und Vertex haben in Grossbritannien die weltweit erste Zulassung einer Therapie erreicht, die auf Genom-Editie...
News 04. Okt. 2023 US health agency links up with the Paul Scherrer Institute Researchers from the Paul Scherrer Institute are working on an efficient method of mapping the brain of a mouse. As part of the BRAIN Initiative,...
SWISS Pavilion SWISS Pavilion @ Arab Health 2025 27. Jan. 2025–30. Jan. 2025 Vereinigte Arabische Emirate
News 26. Apr. 2023 Siegfried breaks ground on new global R&D Center for Drug Substances in Evionnaz Siegfried will create a new global R&D Center in Evionnaz, investing CHF 25 million to boost capacity, drive growth, and leading to the creation ...
Actualités 11. Okt. 2023 Lonza élargit davantage ses capacités de fabrication d’ADC à Viège Lonza amplifie sa production d’ADC via une extension importante de la capacité de bioconjugaison de son Ibex Dedicate Biopark à Viège, ce qui dev...